Exploring the HIF-1α signalling pathway and the mechanism of YiQiHuoXue decoction against Precancerous Lesions of Gastric Cancer based on Network Pharmacology and Molecular Docking

Citations Over Time

Abstract

Precancerous Lesions of Gastric Cancer (PLGC) are an essential step in the advancement of Gastric cancer (GC). Early intervention represents the most effective strategy to impede the development of PLGC. However, additional research is necessary to comprehend the molecular mechanism of PLGC. YQHXD is originated from Si Wu Decoction, has been utilized as an empirical formula for the treatment of PLGC for several years. In this study, we employed network pharmacology, molecular docking, and experimental validation to examine the inhibitory and ameliorative properties of YQHXD on PLGC. Multiple databases were utilized to gather genetic information on drugs in PLGC and YQHXD, in order to obtain cross-targets. We discovered 142 common targets between YQHXD and PLGC. GO and KEGG enrichment analyses indicate that YQHXD treatment of PLGC might be linked with cellular response to oxygen levels and the HIF-1α signaling pathway. Finally, we performed in vitro experiments, of which the results reveal that YQHXD mitigates gastric mucosal atrophy, intestinalization, and heterogeneous hyperplasia, and reduces the expression of inflammatory factors in rats. Therefore, we considered that YQHXD has the potential to delay the PLGC process by inhibiting the HIF-1α signaling pathway.

Related Papers

• Effects of Zhizhu Pill Decoction and Zhizhu Decoction on P Substance in Rats(2007)
• Influence of Banxiaxiexin Decoction and compatibilities of its analogous decoctions on principles of gastric juice in rats(2006)
• Experimental Study on Effect of Sijunzi Decoction and Siwu Decoction on IL-2 of Subacute Aging Model Mice(2013)
• Optimization of Decoction Technology of Yangxinfang Decoction by Orthogonal Experiment(2010)
• → Meta-analysis of Xiaochaihu Decoction in the Treatment of Cancer Fever(2021)